Rohit Singh

Rohit Singh is a finance professional with extensive experience in investor relations and corporate finance. As a Senior Analyst for Investor Relations at ARCHIMED since March 2023, Rohit focuses on impacting healthcare through strategic financial communication. Previously, as a Junior Treasury & Investor Relations Coordinator at ADVA, Rohit managed daily cash operations, developed investor presentation materials, analyzed foreign exchange strategies, and supported sustainable supplier initiatives. Prior roles include a Venture Capital Analyst at Merck Group, where Rohit conducted due diligence and portfolio management, and a Credit Analyst for Corporate Bonds at UniCredit, focusing on financial modeling and operational analysis. Rohit holds an MSc in Finance from Grenoble Ecole de Management and is a CFA Level 2 candidate.